Therapeutic applications of nanobodies against SARS-CoV-2 and other viral infections: Current updateReview Published on 2023-02-282023-07-11 Journal: International journal of biological macromolecules [Category] COVID19(2023년), [키워드] nanobodies neutralization SARS-CoV-2 virus. [DOI] 10.1016/j.ijbiomac.2022.12.284 PMC 바로가기 [Article Type] Review
Novel Affibody Molecules Specifically Bind to SARS-CoV-2 Spike Protein and Efficiently Neutralize Delta and Omicron VariantsArticle Published on 2023-02-142023-07-11 Journal: Microbiology Spectrum [Category] COVID19(2023년), [키워드] affibody FP fusion peptide neutralization RBM receptor binding motif S protein SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2. SPR [DOI] 10.1128/spectrum.03562-22 PMC 바로가기
Highly efficacious and safe neutralizing DNA aptamer of SARS-CoV-2 as an emerging therapy for COVID-19 diseaseArticle Published on 2022-12-302023-07-11 Journal: Virology Journal [Category] COVID19(2023년), [키워드] ACE2 aptamer COVID-19 neutralization RBD Safety SARS-CoV-2 Spike S protein Toxicity virus. VLP [DOI] 10.1186/s12985-022-01943-7 PMC 바로가기
Characterization and Function of Glycans on the Spike Proteins of SARS-CoV-2 Variants of ConcernArticle Published on 2022-12-212023-07-10 Journal: Microbiology Spectrum [Category] COVID19(2023년), [키워드] glycosylation pattern neutralization Receptor binding SARS-CoV-2 variants of concern. [DOI] 10.1128/spectrum.03120-22 PMC 바로가기
SARS-CoV-2 Spike Protein-Activated Dendritic Cell-Derived Extracellular Vesicles Induce Antiviral Immunity in MiceArticle Published on 2022-12-122023-07-10 Journal: ACS Biomaterials Science & Engineering [Category] COVID19(2023년), [키워드] DC-derived extracellular vesicle Humoral response neutralization SARS-CoV-2 vaccine. [DOI] 10.1021/acsbiomaterials.2c01094 PMC 바로가기
Omicron neutralizing antibody response following booster vaccination compared with breakthrough infectionArticle Published on 2022-12-092023-07-10 Journal: Med (New York, N.Y.) [Category] COVID19(2023년), [키워드] antibody Breakthrough infection COVID-19 Immunity neutralization omicron Translation to patients vaccination. [DOI] 10.1016/j.medj.2022.09.001 PMC 바로가기
Duration of BA.5 neutralization in sera and nasal swabs from SARS-CoV-2 vaccinated individuals, with or without omicron breakthrough infectionArticle Published on 2022-12-092023-07-10 Journal: Med (New York, N.Y.) [Category] COVID19(2023년), [키워드] BA.5 breakthrough IgA IgG mucosal immunity neutralization omicron SARS-CoV-2 Translation to patients Vaccine variants. [DOI] 10.1016/j.medj.2022.09.010 PMC 바로가기
Non-Neutralizing Epitopes Shade Neutralizing Epitopes against Omicron in a Multiple Epitope-Based VaccineArticle Published on 2022-12-092023-07-10 Journal: ACS Infectious Diseases [Category] COVID19(2023년), [키워드] antibody immunodominant site linear epitopes neutralization SARS-CoV-2 variants. [DOI] 10.1021/acsinfecdis.2c00488 PMC 바로가기
Design and performance characteristics of the Elecsys anti-SARS-CoV-2 S assayArticle Published on 2022-12-022023-07-11 Journal: Frontiers in Immunology [Category] COVID19(2023년), [키워드] COVID-19 neutralization quantitative serology SARS-CoV-2 sensitivity specificity. [DOI] 10.3389/fimmu.2022.1002576 PMC 바로가기
ACE2 decoy receptor generated by high-throughput saturation mutagenesis efficiently neutralizes SARS-CoV-2 and its prevalent variants고처리량 포화 돌연변이 유발에 의해 생성된 ACE2 미끼 수용체는 SARS-CoV-2 및 그 유행하는 변이체를 효율적으로 중화합니다Article Published on 2022-12-012022-09-11 Journal: Emerging Microbes & Infections [Category] COVID19(2023년), SARS, 변종, [키워드] ACE2 ACE2 binding ACE2-RBD binding approach binding binding affinity C-terminal cellular receptor changes in convalescent sera Critical critical point D614G decoy receptor domain Effect fused global pandemic glycosylation site High-throughput screening increase in Microarray monoclonal antibodies Mutagenesis mutations neutralization neutralize neutralized Omicron variant Point mutation prevalent protease Protein protein engineering. Pseudotyped virus RBD RBD binding RBD-ACE2 receptor Receptor binding domain rescued SARS-CoV-2 SARS-CoV-2 virus significantly single-cell soluble ACE2 Spike protein the SARS-CoV-2 the SARS-CoV-2 virus therapeutic potential Treatment Vaccine variant variants viral entry viral spike protein wild-type [DOI] 10.1080/22221751.2022.2079426 PMC 바로가기 [Article Type] Article